• 1
    Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:7881.
  • 2
    Nishida Y, Morita H, Minamino N, et al. Effects of brain natriuretic peptide on hemodynamics and renal function in dogs. Jpn J Physiol 1990;40:531540.
  • 3
    Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195203.
  • 4
    Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004;6:257260.
  • 5
    Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000;36:355359.
  • 6
    Mueller T, Gegenhuber A, Dieplinger B, et al. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med 2004;42:942944.
  • 7
    Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 2004;10 (Suppl 3):130.
  • 8
    Oyama MA, Fox PR, Rush JE, et al. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc 2008;232:14961503.
  • 9
    Boswood A, Dukes-McEwan J, Loureiro J, et al. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 2008;49:2632.
  • 10
    Fine DM, Declue AE, Reinero CR. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease. J Am Vet Med Assoc 2008;232:16741679.
  • 11
    Rademaker MT, Charles CJ, Kosoglou T, et al. Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure. Am J Physiol 1997;273 (Part 2):H2372H2379.
  • 12
    Hall C. NT-proBNP: The mechanism behind the marker. J Card Fail 2005;11 (Suppl):S81S83.
  • 13
    McCullough PA, Sandberg KR. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 2003;4 (Suppl 4):S13S19.
  • 14
    Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Am Coll Cardiol 2006;47:9197.
  • 15
    Austin WJ, Bhalla V, Hernandez-Arce I, et al. Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease. Am J Clin Pathol 2006;126:506512.
  • 16
    Khan IA, Fink J, Nass C, et al. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol 2006;97:15301534.
  • 17
    Schmidt MK, Reynolds CA, Estrada AH, et al. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: A pilot study. J Vet Cardiol 2009;11:S81S86.
  • 18
    Andrews F, Morgan J, Sonquist J, Klein L. Multiple Classification Analysis, 2 ed. Ann Arbor: University of Michigan; 1973.
  • 19
    Kruskall W, Wallis W. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47:583621.
  • 20
    Dineen L, Blakesley B. Algorithm AS 62: Generator for the sampling distribution of the Mann-Whitney U statistic. Appl Stat 1973;22:269273.
  • 21
    Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:6570.
  • 22
    Rogers J, Nicewander W. Thirteen ways to look at the correlation coefficient. Am Stat 1988;42:5965.
  • 23
    Vickery S, Price CP, John RI, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: Relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 2005;46:610620.
  • 24
    Heiene R, Moe L. Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: A review. J Vet Intern Med 1998;12:401414.
  • 25
    Olsen MH, Hansen TW, Christensen MK, et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 2005;46:660666.
  • 26
    Lalor SM, Connolly DJ, Elliot J, Syme HM. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease. J Vet Cardiol 2009;11:S71S79.
  • 27
    Nicolle AP, Chetboul V, Allerheiligen T, et al. Azotemia and glomerular filtration rate in dogs with chronic valvular disease. J Vet Intern Med 2007;21:943949.